CCIA
BMY icon

Campbell & Co Investment Adviser’s Bristol-Myers Squibb BMY Stock Holding History

Campbell & Co Investment Adviser’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.78M Buy
+29,424
New +$1.72M 0.1% 318
2025
Q4 		– Sell
-128,750
Closed -$5.81M – 1147
2025
Q3 		$5.81M Buy
128,750
+85,752
+199% +$4M 0.44% 17
2025
Q2 		$1.99M Buy
+42,998
New +$2.11M 0.13% 251
2024
Q3 		– Sell
-37,382
Closed -$1.55M – 1101
2024
Q2 		$1.55M Buy
37,382
+24,403
+188% +$1.09M 0.13% 230
2024
Q1 		$704K Sell
12,979
-5,341
-29% -$272K 0.06% 550
2023
Q4 		$940K Sell
18,320
-17,382
-49% -$912K 0.08% 415
2023
Q3 		$2.07M Buy
35,702
+28,823
+419% +$1.77M 0.25% 83
2023
Q2 		$440K Buy
6,879
+2,440
+55% +$164K 0.08% 496
2023
Q1 		$308K Sell
4,439
-7,927
-64% -$559K 0.06% 595
2022
Q4 		$890K Sell
12,366
-5,028
-29% -$379K 0.21% 127
2022
Q3 		$1.24M Buy
17,394
+6,278
+56% +$455K 0.28% 80
2022
Q2 		$856K Buy
11,116
+8,315
+297% +$633K 0.23% 110
2022
Q1 		$205K Sell
2,801
-2,099
-43% -$141K 0.06% 624
2021
Q4 		$306K Buy
+4,900
New +$287K 0.1% 352
2021
Q2 		– Sell
-12,264
Closed -$774K – 534
2021
Q1 		$774K Buy
+12,264
New +$763K 0.48% 40
2019
Q4 		– Sell
-8,656
Closed -$439K – 651
2019
Q3 		$439K Buy
+8,656
New +$407K 0.17% 223
2018
Q4 		– Sell
-5,577
Closed -$346K – 343
2018
Q3 		$346K Buy
+5,577
New +$331K 0.24% 165
2018
Q1 		– Sell
-4,131
Closed -$253K – 369
2017
Q4 		$253K Buy
+4,131
New +$258K 0.19% 249
2017
Q3 		– Sell
-3,888
Closed -$217K – 358
2017
Q2 		$217K Buy
+3,888
New +$212K 0.2% 233
2016
Q4 		– Sell
-5,551
Closed -$299K – 145
2016
Q3 		$299K Buy
+5,551
New +$357K 0.81% 51
2014
Q2 		– Sell
-18,412
Closed -$957K – 164
2014
Q1 		$957K Buy
+18,412
New +$980K 0.39% 83

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Campbell & Co Investment Adviser's BMY Position: Q1 2026 in Review

Campbell & Co Investment Adviser opened a new position in Bristol-Myers Squibb (BMY) in Q1 2026: 29,424 shares worth $1.78M. The stake represents 0.1% of the portfolio and ranks #318 among its holdings. This is a return to the name: Campbell & Co Investment Adviser previously reported a position in BMY as recently as Q3 2025.

Campbell & Co Investment Adviser first reported a position in BMY in Q1 2014 and has held it in 21 quarters since. The position peaked at $5.81M in Q3 2025. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Campbell & Co Investment Adviser held 29,424 shares of Bristol-Myers Squibb worth $1.78M as of Q1 2026.
  • Bristol-Myers Squibb was a new Campbell & Co Investment Adviser position in Q1 2026.
  • Bristol-Myers Squibb made up 0.1% of Campbell & Co Investment Adviser's portfolio in Q1 2026, its #318 holding.
  • Campbell & Co Investment Adviser first reported a position in Bristol-Myers Squibb in Q1 2014 and has held it in 21 quarters since.
  • Campbell & Co Investment Adviser's Bristol-Myers Squibb position peaked at $5.81M in Q3 2025.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Campbell & Co Investment Adviser's 13F filing for Q1 2026, filed 15 May 2026.